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Meeting children’s vitamin A (VA) needs remains a policy priority. Doing so efficiently is a fiscal imperative and
protecting at-risk children during policy transitions is a moral imperative. Using the Micronutrient Intervention
Modeling tool and data for Cameroon, we predict the impacts and costs of alternative VA intervention programs,
identify the least-cost strategy for meeting targets nationally, and compare it to a business-as-usual (BAU) strategy
over 10 years. BAU programs effectively cover ∼12.8 million (m) child-years (CY) and cost ∼$30.1 m; ∼US$2.34
per CY effectively covered. Improving the VA-fortified oil program, implementing a VA-fortified bouillon cube
program, and periodic VA supplements (VAS) in the North macroregion for 3 years effectively cover ∼13.1 m CY
at a cost of∼US$9.5 m, or∼US$0.71 per CY effectively covered. The tool then identifies a sequence of subnational
policy choices leading from the BAU toward the more efficient strategy, while addressing VA-attributable mortality
concerns. By year 4, fortification programs are predicted to eliminate inadequate VA intake in the South and Cities
macroregions, but not the North, where VAS should continue until additional delivery platforms are implemented.
This modeling approach offers a concrete example of the strategic use of data to follow the Global Alliance for VA
framework and do so efficiently.
Keywords: vitamin A; children; dietary intake; modeling; cost-effectiveness; policy pathways; Cameroon
Introduction
Vitamin A deficiency (VAD) affects hundreds
of thousands of children globally, particularly in
low- and middle-income countries (LMIC),1 and
increases their risk of morbidity and mortality.2
Results from large randomized, controlled tri-
als have indicated that vitamin A supplementa-
tion (VAS) of children conducted in areas with a
high risk of VAD reduces mortality.3–5 Based on
these results, national programs have been imple-
mented in multiple countries to provide children
with high-dose VAS distribution semiannually. In
many countries, VAS distribution has been linked
to vaccination campaign platforms, such as Child
Health Days (CHD).6 These programs were ini-
tially intended as a short-term solution, to mit-
igate the loss of life, while other medium- and
long-term strategies to address underlyingVADand
low intake were put in place, but have now been
operating for decades in many countries. While
some countries have made progress in address-
ing VAD through other programs, such as forti-
fication (e.g., Guatemala7), many countries either
do not have such alternative programs in place, or
the programs are not functioning well.8,9 At the
same time, as vaccine-preventable diseases such
as polio near eradication, funding for the deliv-
ery platforms that have been used for VAS distri-
bution has been reduced.10 Some countries (e.g.,
Ethiopia) have switched to other delivery platforms
doi: 10.1111/nyas.14275
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for VAS, such as during routine healthcare contacts,
but these systems are often weak in low-income
settings. Countries that lose funding for twice-
annual VAS distribution but do not yet have other
systems in place for VAS distribution or other vita-
min A (VA) programs will be at risk of experiencing
increased child mortality.
In countries where VA programs, such as
food fortification, have been implemented, the
Global Alliance for Vitamin A (GAVA) proposed
a framework for deciding when to scale back
VAS distribution;11,12 this framework was recently
updated.13 The original framework relies on collect-
ing appropriate evidence to indicate that programs
to increase daily VA intake are functioning well and
that VAD has been reduced below selected thresh-
olds. Specifically, the framework recommends that
countries (1) collect dietary data and program
monitoring data to assess whether programs are
working well and diets are improving; (2) conduct
a survey using VA biomarkers among children
(hereafter, referred to as a validation study) to
assess whether the prevalence of VAD (typically
measured using serum retinol) has decreased;
(3) if the prevalence of VAD is <5%, conduct a
second validation study in a nonconsecutive year
to confirm the change in VA status; and (4) if the
decrease in VAD is confirmed, withdraw the VAS
program, with appropriate monitoring during the
transition.12 The new framework relaxes these
conditions somewhat by recommending that VAS
program scale back be considered in populations
where the prevalence of VAD (determined using
biomarkers) is <10% and dietary intake is shown
to be adequate for the population.13 Both versions
of the framework are intended for use once alter-
native VA programs are up and running, but they
do not include guidance for countries on how to
select or implement the appropriate program, or
combination of programs, to reach the point where
VAD is likely to have decreased and the GAVA
framework can be applied to policy discussions
about withdrawing VAS.
The Micronutrient Intervention Modeling pro-
ject (MINIMOD) aims to fill this gap by applying
a tool composed of three models (nutrition ben-
efits, program costs, and economic optimization)
to design and manage micronutrient (MN) inter-
vention programs more efficiently. By predicting
the costs and likely health and nutrition impacts
of selected existing and new programs, the tool
provides information that can be introduced into
policy discussions to improve the cost-effectiveness
of national and subnational MN strategies. Pre-
viously, the MINIMOD tool was applied to the
case of VA programs in Cameroon (where baseline
VAD rates among young children ranged from over
40% inflammation-adjusted retinol-binding protein
<0.83 μmol/L in theNorthmacroregion to less than
25% in the Southmacroregion), to identify themost
cost-effective mix of programs that would achieve
the same effective coverage as current (business-as-
usual, BAU)programs (VAS, deworming (DW), and
fortified edible oil).14–17 VA-related programs intro-
duced into the MINIMOD tool included high-dose
VAS distributed via CHD, multiple MN powders
also distributed via CHD, large-scale food fortifica-
tion, and VA-biofortification of maize.a The results
suggested that modifying the composition of pro-
grams and shifting the geographic focus of VA pro-
grams to the North macroregion (where the burden
of VAD was greatest and where VAS programs were
most efficient) could achieve the same effective cov-
erage as the current portfolio, at approximately 50%
lower cost.17
The objectives of this paper are to apply the
MINIMOD tool to update the model with a revised
set of VA intervention programs and data to sup-
port them, and to identify concrete subnational
policy pathways (sequences of VA program mod-
ifications) in Cameroon, which are guided by
the GAVA framework.b More specifically, we (1)
apply the MINIMOD tool to estimate the impacts,
costs, and cost-effectiveness of policy-relevant VA
intervention programs over 10 years for three eco-
logical macroregions of Cameroon; (2) apply the
MINIMOD tool’s economic optimization model to
aOther programs and policies that could influence the
prices or availabilities of VA-rich foods have not been
included in the MINIMOD tool to date; among other sci-
entific gaps, convincing evidence on the impacts of these
programs/policies on VA intake of young children is not
yet available.
bThe present paper focuses on the original GAVA frame-
work, but a similar approach could be used to apply the
MINIMOD tool to the updated GAVA framework. How-
ever, the core results presented here and their implications
for policy would not change.
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identify the most cost-effective strategy for meet-
ing VA nutrition objectives nationally; and then
(3) identify macroregional, year-by-year policy
pathways (programmatic changes) leading from a
BAU scenario toward more efficient sets of policies
that achieve adequate VA intake while protecting
children from VAD-related mortality during policy
transitions.
Methods
Previously, we used the MINIMOD tool’s nutri-
tion benefits model to predict the effects of alter-
native VA intervention programs, and combina-
tions thereof, on dietary VA adequacy15 and lives
saved.18 Using the tool’s cost model,16 we estimated
program costs over 10 years, including start-up
costs of all VA intervention programs and combi-
nations of them. We then applied the MINIMOD
tool’s economic optimization model17 to identify
the most cost-effective strategy to meet VA needs
over 10 years, compared with programs in place
under a BAU strategy. For our analysis here, we
updated the results of the foregoing analyses with
a slightly different set of VA interventions and used
the economic optimization model to identify prac-
ticalmacroregion–specific policy pathways that lead
from the BAU strategy to a more efficient set of
VA programs, but constrained to adhere to the
original GAVA framework. Finally, we calculated
the costs associated with adhering to the GAVA
protocol.
VA intervention programs modeled
A broad array of programs and policies exist that
have the potential to directly (e.g., via food for-
tification) or indirectly (e.g., price policies that
incentivize the consumption of VA-rich foods)
increase VA intake. Decision makers in Cameroon
were most interested in a subset of programs that
were underway or were being discussed as pos-
sible additional/replacement interventions. More
specifically, a fortification program for edible oils
(consumed on the previous day by 39% (South
macroregion) to 79% (Yaoundé/Douala)19 of chil-
dren nationally, and fortified with VA) was ongoing
but could be strengthened, a VA-biofortified maize
program was being considered (any maize con-
sumption by children on the previous day ranged
from 34% (Yaoundé/Douala) to 45% of children
(North macroregion)19), as was the fortification of
bouillon cubes (consumed on the previous day by
>86% of children in each macroregion).c In addi-
tion, twice-annual distribution of high-dose VAS
has been ongoing in Cameroon for decades, with
reach varying regionally and over time. DW treat-
ment is also included in the programs in Cameroon,
but we have excluded this from the current calcula-
tions due to the low hypothetical contribution toVA
status.
Estimation of VA intervention program benefits
The target population for VA intervention pro-
grams in Cameroon is children 6–59 months of age.
We calculated three indicators of program impact
(reach, effective coverage,15 and lives saved18).
Reach was defined as the proportion of individuals
who consumed any additionalVAbecause of a given
program, regardless of howmuch additionalVAwas
consumed, or whether an individual had low VA
intake or status. Effective coverage was defined as
the proportion of individuals who had inadequate
dietary VA intake and subsequently achieved ade-
quate intake as a result of one or more VA inter-
vention programs. Effective coverage was calculated
by estimating the prevalence of dietary VA ade-
quacy at baseline (intake from typical diet alone)
and under different programmatic scenarios (e.g.,
edible oil or bouillon cube fortification, high-dose
VAS administration) to calculate the increase in pro-
portion of individuals with adequate VA intake. The
Lives Saved Tool (LiST) model20 was used to esti-
mate the effects on VA-related child mortality of
alternative VA intervention programs, and combi-
nations of them.18
The data used to estimate the baseline preva-
lence of inadequate nutrient intakes were collected
during a 2009 national survey of MN status and
dietary intake in Cameroon, stratified at the level
of three macroregions: North, South, and Cities
(Yaoundé and Douala).19,21 The dataset includes at
least 1 day of dietary intake data for all respondents,
and a second day of data for a subset of respon-
dents, to enable estimation of the distribution of
habitual (as compared with a single-day) dietary
intake.22 We applied the National Cancer Institute
cOther candidate VA delivery vehicles could easily be
introduced into the MINIMOD tool.
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(NCI) method23,24 to generate the distribution of
usual nutrient intakes and estimate the prevalence
of inadequate intake (i.e., proportion with intakes
below the age- and sex-specific estimated average
requirement ) at baseline (i.e., in the absence of any
MN intervention programs, such as fortification or
supplementation). Nationally, roughly half of chil-
dren in this age group suffered from inadequate
VA intake; however, this national average masks
substantial macroregional variation, ranging from
35% in the South macroregion to 73% in the North
macroregion. Notably, these regional patterns of the
prevalence of inadequate VA intake were similar to
the observed patterns of VA deficiency (defined as
low inflammation-adjusted plasma retinol-binding
protein concentrations or as low breast milk VA
concentrations),14,25 in that both dietary intake and
biomarkers identified the population in the North
macroregion as having the greatest risk of low VA
intake and status.
We simulated the effects of VA intervention pro-
grams, and combinations of them, by calculating
the additional daily VA intake contributed by one
or more programs and adding this to each per-
son’s baseline intake. The specific method applied
for each type of intervention program is described
below. We then reapplied the NCI method to esti-
mate the postintervention distribution of usual
intakes and prevalence of inadequate intake under
each scenario.26 Finally, effective coverage was cal-
culated as the difference between prevalence of
inadequate intake in each modeled scenario com-
pared with the baseline.
To estimate the contribution of fortified edible
oil to dietary VA intake, we multiplied fortifiable
oil consumption (grams per day) by the assumed
fortification level. Two scenarios were modeled: (1)
implementation ofVA fortification at 44%of the tar-
get level of 12 mg/kg of oil, based on measurements
of fortified oil samples from a program evaluation;21
and (2) an enhanced program,where, through addi-
tionalmonitoring and enforcement activities, the oil
fortification levels are increased gradually from 44%
of target to 100% of the target level over a period of
3 years. Fortified bouillon cube impacts were esti-
mated in the same way, under the assumption that
3 years of program planning would be necessary
before 100% of bouillon cube would be fortified
(80 mg/kg of bouillon cube) beginning in year 4 of
the simulation.
To estimate the contribution of biofortified
maize, we assumed that the consumed product con-
tains 0.34 μg of beta-carotene RAE per kcal,27 and
that after a 3-year phase-in period during which
nationwide investments are made in agroecozone-
specific varietal improvements and agricultural
extension, all maize in the national marketplace is
biofortified at that level.d
To estimate the contribution of high-dose VA
supplements to dietary VA adequacy, a daily intake
equivalent of 167 μg retinol activity equivalents per
day (RAE/day) was developed;15 this amount was
added to the baseline VA intake for all children who
reportedly received a VA supplement during the
6 months prior to the dietary survey. The reach of
VAS was assumed to remain the same as that mea-
sured in the dietary survey (64% South, 89% North,
and 58% Yaoundé/Douala).
Linkage with LiST. We estimated the number of
child deaths averted through VA intervention pro-
grams by introducing effective coverage estimates
into Lives Saved Tool (LiST)20 through an adapted
method that has been described previously.18
Briefly, LiST projection files were created for each
of the three macroregions to estimate the cause of
death structure among children <5 years of age.
The LiST tool, as originally developed, estimates
the contribution of high-dose VAS (but not other
VA interventions) to reductions in child mortal-
ity. We modified the parameters in the original
LiST method to predict the effect of achieving
adequate VA intake (effective coverage) on VA-
related child mortality. Specifically, we substituted
effective coverage estimates for VAS coverage (i.e.,
receipt of a capsule) and derived an estimate of
the effectiveness of achieving dietary adequacy for
reducing diarrheal deaths, the main contributor to
VA-preventable child deaths in LiST. To estimate
the total number of VA-preventable deaths in each
macroregion, the baseline coverage of VAS in LiST
was first rolled back to zero to simulate a scenario in
which no VA interventions are in place. From this
dFortification levels were taken from HarvestPlus.26
Assumptions regarding adoption by farmers and con-
sumption by households are purposefully very optimistic;
if this delivery platform is not cost-effective under these
assumptions, thenweaker,more realistic assumptionswill
only reduce its cost-effectiveness.
164 Ann. N.Y. Acad. Sci. 1465 (2020) 161–180 © 2019 The Authors. Annals of the New York Academy of Sciences
published by Wiley Periodicals, Inc. on behalf of New York Academy of Sciences
Vosti et al. Meeting children’s vitamin A needs in Cameroon
baseline coverage of zero, VA programs are then
scaled up in the LiST projection file by using the
effective coverage estimates for various packages
of VA interventions (generated through the dietary
modeling described above) to calculate deaths
averted in each scenario.
Estimation of VA intervention program costs
To estimate the costse ofVAprograms inCameroon,
we used recent budgets from current programs,
when available.16 When program budgets were not
available, for example, for experimental delivery
platforms or planned improvements to existing plat-
forms, we estimated costs based on known unit
costs of program components and expert knowl-
edge distilled from a cost workshop convened in
Cameroon in April, 2014.16
Large-scale food fortification. Costs of large-
scale fortification programs were drawn primarily
from budgets created by Helen Keller International-
Cameroon. Program costs included program
planning costs, up-front investments required to
outfit edible oil filtering/containerizing production
processes to blend in fortificants, the costs of forti-
ficants, and the private and public costs associated
with program monitoring and evaluation. The
costs associated with designing and implementing
a fortified bouillon cube program, including a
3-year start-up period during which costs would
be incurred but no nutritional benefits would be
generated, were based on input provided at a 2014
cost workshop by members of the food industry
and organizations that designed and managed the
national edible oil and wheat flour fortification
programs.
In some of the results that follow, we examined
the potential effects of improving the efficiency and
effectiveness of current large-scale fortification pro-
grams, by increasing investments in the monitoring
and evaluation of programs to ensure full industry
compliance.f
eAll costs are reported in 2013 USD, using an exchange
rate of 500 CFA = 1 USD.
fThe incremental programmatic activities and costs asso-
ciated with program improvements were identified by
experts at costingworkshops convened by theMINIMOD
tool in Cameroon.
Biofortification of maize. Biofortification refers
to the process of selectively breeding varieties of sta-
ple crops so that they contain higher-than-average,
bioavailable amounts of key MNs.27 The data for
maize biofortification program cost estimates were
drawn from budgets developed during a workshop
involving experts from Cameroon on biofortifica-
tion. The very large up-front research and develop-
ment costs associated with fundamental trait selec-
tion and plant breeding are generally paid by the
international community (e.g., by one of more of
the centers that comprise the Consultative Group
on International Agricultural Research–CGIAR),
and hence were not included as costs to national
biofortification programs. However, program costs
included in-country varietal selection and agro-
nomic improvement activities, as well as the costs
associated with seed multiplication and agricultural
extension programs required to ensure the avail-
ability and proper use of new planting material. No
nutritional benefits were assumed to emerge from
biofortification programs during the first 3 years of
their operation.
VAS distribution through child health days.
CHDs inCameroon target all children 6–59months
of age, regardless of their health or nutritional sta-
tus.g These twice-annual CHD campaigns are large
and expensive.16 The data used to estimate the costs
of CHDwere primarily drawn from budgets created
by United Nations Children’s Fund-Cameroon and
Helen Keller International-Cameroon for the dis-
tricts they managed during the second round of the
CHD campaign in 2012.h Cost categories included,
among other things: (1) the distribution of the VA
capsules to the children through door-to-door vis-
its; (2) VA capsule costs, including freight and deliv-
ery costs; (3) campaign personnel supervision, per
diem, transportation, and other costs; (4) training
costs; (5) TV and radio communication costs; (6)
costs of collecting and processing program eval-
uation data; and (7) national-level administrative
costs.
An array of products and services are generally
provided during CHDs, for example, the distribu-
tion of high-dose VAS and DW tablets, catch-up
gVAS program reach, as of 2009, varied by macroregion
(North = 89%, South = 64%, and Cities = 58%).
hFor details of cost calculations, see Kagin et al.16
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immunizations, and sometimes oral polio vaccine.
For the purposes of this paper, we focused only on
VAS. To isolate the costs of these interventions, we
first removed costs directly related to vaccinations,
for example, vaccination teams, vaccination train-
ing, vaccine costs, and so on. We then assumed that
90% of the overhead costs associated with CHDs
would have to be covered by the VAS program.i ,j
Economic optimization model to identify the
most cost-effective set of VA intervention pro-
grams. We used the MINIMOD economic opti-
mization model to identify the most cost-effective
strategy for addressing inadequateVA intake among
young children.17 More specifically, the model uses
a mixed integer linear programming approach that
aims, in the results presented below, to effectively
cover at least the same number of child-years (CY)k
i Funds for platforms delivering core services (e.g., polio)
onto which VAS programs have been appended are dis-
appearing. This is prompting discussions regarding the
extent to which VAS and other stakeholder groups would
be willing to contribute more than the marginal costs
of their specific products (e.g., DW tablets) or services
(e.g., breastfeeding guidance) to sustain CHD and other
campaign-based programs. In the context of Cameroon,
VAS program advocates were the only groups willing to
covermore than themarginal cost of product/service pro-
vision. In other words, many groups were willing to pur-
chase a seat on the bus, but nobody was willing to pay the
fuel, the driver, organizing the trip, and so on. Hence, in
our calculations, themajority of overhead costs were allo-
cated to VAS programs.
jModel testing around this critical assumption suggested
that allocating 50% or more of CHD overhead costs to
VAS programs generates roughly the same set of cost-
effective VA intervention programs. VA-fortified edible
oils and the focus on VAS in the North macroregion
remain the same, with VA-fortified bouillon cubes and
VA-biofortified maize appearing in fewer Monte Carlo
simulations than is the case when full CHD overhead
costs are included in the model. As expected, the average
cost per child-year effectively covered is somewhat lower
for the low-overhead scenario ($0.68 versus $0.71). See
Table 6.
kIt is not possible to know which specific children
receive VAS or who consume fortified or biofortified
foods/condiments and whether the same individuals
would be effectively covered each year (and diets may
change over time). Therefore, we use the metric “child-
(nationally) over 10 years as the BAU scenario,l
but including a broader array of candidate VA
intervention programs. The set of candidate pro-
grams included in the optimization algorithmwere,
among others: current VA-fortified edible oil pro-
gram, enhanced VA-fortified edible oil programs,
VA-fortified bouillon cubes, VA-biofortified maize,
and VAS programs that can be deployed at the
macroregional level. The model was free to shift
resources across VA intervention programs, across
macroregions, and over time with the objective of
seeking the most cost-effective collection of pro-
grams that can meet (at least) the national BAU
programs’ outcomes, namely CY effectively covered
and lives saved over the entire 10-year planning
time horizon. The BAU programs were composed
of a national VA-fortified edible oil program that
nationally delivers approximately 44% of the tar-
geted amount of VA and a national VAS program
delivered via CHD.m
Policy pathways for improving the efficiency of
VA programs. The MINIMOD economic opti-
mization model will identify themost cost-effective
combinations of VA intervention programs nation-
ally over 10 years for meeting a prespecified target,
in this case, the number of CY effectively covered
by the BAU programs. However, transitioning from
the BAU set of programs to the economically opti-
mal set of programs will not be immediate or free
of additional costs; a variety of technical, political,
and other issues will also need to be addressed,
and investments may be required to upgrade
existing programs and to put new programs in
years” to refer to the total number of children who are
effectively covered by one of more VA intervention pro-
grams, understanding that some children might be effec-
tively covered 1 year, and not the next.
lThe BAU strategy is, by design, a 10-year projection of
recent national VA intervention programs in Cameroon,
namely: a VA-fortified edible oils program operating at
∼44% of target levels, and the national distribution of
VAS to children aged 6–59 months via CHDs.
mThe BAU and economically optimal model results pre-
sented here are slightly different from those presented in
Vosti et al.;17 small upgrades have been introduced into
the model, and the modest costs and nutritional bene-
fits associated with DW tablets (distributed during CHD)
have been removed.
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place. Depending on the issues to be addressed
and the program upgrades to be made, progress
can be quicker or slower, and progress can vary by
macroregion. Moreover, achieving the nationally
economically optimal solution will generally
involve trade-offs across macroregions regarding
where cases of VAD are resolved; by design, the
model takes advantage of macroregional differ-
ences in VAD and region-specific differences in the
cost-effectiveness of alternative VA intervention
programs in addressing VAD. It is possible that
some trade-offs suggested by the model may be
deemed unacceptable for political or other reasons,
and objectives may be established for macroregions
rather than for the entire nation.
Therefore, it is important to identify policy path-
ways (sequences of policy changes that lead from
the BAU set of VA intervention programs towards
a final set of more efficient programs) that address
these issues, and thereby generate political sup-
port for medium-term strategies for reducing MN
deficiencies, and help secure financial support for
these transitions. TheMINIMOD tool allows for the
examination of multiple pathways leading from the
BAU strategy toward the economically optimal set
of VA intervention programs for each macroregion,
on an annual time-step. In what follows, we use the
MINIMOD tool to examine one such pathway for
each of Cameroon’s macroregions separately,n with
the added condition that the pathway adhere to the
GAVA protocol for assessing the wisdom of scal-
ing back VAS programs. More specifically, the tool
seeks the most cost-effective collection of VA inter-
vention programs but requires the retention of VAS
programs until VAD among children is confirmed
to fall below an agreed-upon level. For this analy-
sis, the dietary threshold we adopted for triggering
a validation study to confirm decrease in prevalence
of VAD was the prevalence of inadequate intake
below 2.5% among children 6–59 months of age,
representing the theoretical target for food fortifi-
cation programs.28 Moreover, the tool is required
to retain the VAS program for up to 3 additional
nThis very important approach reduces economic effi-
ciency by eliminating the potential for trading off cases of
VAD that are more expensive to resolve in one macrore-
gion with those that are less costly to resolve in another
macroregion.
years, during which validation studies are under-
taken to confirm that the prevalence of biochem-
ically defined VAD has been reduced to levels at
which VAD is no longer considered a public health
problem.We also calculate the difference in costs of
a departure from the original GAVA recommenda-
tions; namely, if it is only feasible (politically, finan-
cially, or otherwise) to conduct a single validation
study compared with two validation studies.
Model robustness tests. There are two (sum-
mary) sources of uncertainty in the MINIMOD
tool: the estimated nutritional benefits and the esti-
mated costs of alternative VA intervention pro-
grams. To assess the extent to which these sources
of uncertainty affect the programs chosen by the
economic optimizationmodel, probability distribu-
tions around the point estimates of benefits and
costs were constructed, and Monte Carlo simu-
lations involving 1000 simulations based on ran-
dom draws from those distributions were per-
formed. Probability distributions were constructed
using standard errors for effective coverage esti-
mates (assuming a normal distribution); for costs,
uniform distributions of costs ±20% were con-
structed to generate 95% intervals.
Results
For each of the VA intervention programs consid-
ered, the projected 10-yearo reach, effective cover-
age, lives saved, and cost-effectiveness measures for
each of these outcomes varied by intervention and
macroregion (Table 1).
In terms of program reach, the VA-fortified
bouillon cube program was predicted to reach the
largest number of children (>29 m children over
10 years).p VAS delivered via CHD would reach the
second-largest number of children (>23.6 m chil-
dren over 10 years). Biofortified maize would reach
the fewest children (∼13.4 m), with fortified oils
reaching approximately 17.2 m children.
oThe 10-year period is reported as Y1–Y10; all calcula-
tions and simulation model results are anchored on 2009
dietary intake data and 2013–2014 program intervention
cost data. Target populations vary over time; population
projections are provided by the LiST model.
pNearly, 94% of individuals reported consuming bouillon
cubes during the 24-h period preceding the dietary recall.
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Table 1. National and subnational predicted nutritional impacts, costs, and cost-effectiveness of selected vitamin A
programs over 10 years
Reach,
’000s of
child-
yearsa
Effective
coverage,
’000s of
child-years
Child deaths
averted,
number of
children
Total cost,f
’000s US$
Cost per
child
reached,
US$
Cost per
child-year
effectively
covered, US$
Cost per
child death
averted,
US$
VA-fortified edible oils (44% target)b
National 17,188 5075 9724 $2657 $0.15 $0.52 $273
Northc 7135 1459 3836 $928 $0.13 $0.64 $242
South 5435 1960 3577 $1015 $0.19 $0.52 $284
Cities 4618 1657 2311 $713 $0.15 $0.43 $309
VA-fortified edible oils (44–100% target)c
National 17,188 8055 15,527 $4851 $0.28 $0.60 $312
North 7135 2669 8354 $1695 $0.24 $0.64 $203
South 5435 3141 4862 $1853 $0.34 $0.59 $381
Cities 4618 2246 2311 $1303 $0.28 $0.58 $564
VA-fortified bouillon cubesd
National 29,039 7731 16,098 $2932 $0.10 $0.38 $182
North 10,958 3300 8653 $1094 $0.10 $0.33 $126
South 12,820 2940 5365 $1195 $0.09 $0.41 $223
Cities 5261 1491 2080 $643 $0.12 $0.43 $309
VA-biofortified maizee
National 13,435 2512 5720 $1398 $0.10 $0.56 $244
North 5734 1512 3975 $618 $0.11 $0.41 $155
South 5713 808 1476 $593 $0.10 $0.73 $402
Cities 1988 192 269 $187 $0.09 $0.97 $696
VA supplementation via child health days
National 23,649 8586 19,267 $26,923 $1.14 $3.14 $1397
North 11,340 5201 13,630 $8766 $0.77 $1.69 $643
South 8918 2131 3889 $12,963 $1.45 $6.08 $3333
Cities 3391 1253 1748 $5194 $1.53 $4.15 $2972
aThe total number of child-years over the 10-year model timeline is national 32.5 m, North 12.7 m, South 13.9 m, and Cities 5.8 m.
bIndicates measured oil fortification levels in 2012.20 VA, vitamin A.
cNorth: Extreme North, North and Adamawa regions; South: South, East, Centre, Littoral, West, Southwest, and Northwest regions
(excluding Yaoundé and Douala); Cities: Yaoundé and Douala.
dIndicates that the fortified oil program is strengthened such that the VA content of oil increases over a 3-year period from 44% to
100% of target fortification levels.
eTen-year averages are reported, even though benefits do not begin to accrue until year 4 of the simulation period (program is assumed
to be implemented at 100% of target beginning in year 4).
fAll costs are reported in 2013 USD; exchange rate applied was 500 CFA = 1 USD.
The number of children reached by all interven-
tions was much larger than the number effectively
covered, which in turn was much larger than the
number of child deaths averted. The ranking of pro-
gram impact changed as the measure of success
moved from reach to effective coverage, reflect-
ing differences in the amounts of VA delivered to
children by each program. The ranking remained
unchanged, however, if child deaths averted was
chosen as the impact measure instead of effective
coverage. The most effective VA intervention pro-
gram over 10 years in terms of effective coverage
(∼8.6 m CY) and lives saved (19,267) was VAS
delivered via CHD. A close second was the
enhanced VA-fortified oil program, which over
10 years would effectively cover ∼8 m CY and
save 15,527 lives. At the other end of the effec-
tiveness spectrum, the biofortified maize program
was estimated to effectively cover ∼2.5 m chil-
dren and to save 5720 lives. The unenhanced
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Table 2. Business-as-usual vitamin A intervention programs for preschool children in Cameroon by program, over
10 years, and annual total costs and child-years effectively covered
Y1 Y2 Y3 Y4 Y5 Y6 Y7 Y8 Y9 Y10
VA supplementation SNC SNC SNC SNC SNC SNC SNC SNC SNC SNC
Fortified edible oils (44%) SNC SNC SNC SNC SNC SNC SNC SNC SNC SNC
Number of child-years
effectively covered
(’000s)
1198 1217 1236 1255 1274 1293 1312 1331 1350 1359
Total cost (’000s USD) $2951 $2963 $2976 $2988 $2999 $3011 $3023 $3035 $3046 $3058
Notes: SNC refers to macroregions in Cameroon: S, South; N, North; and C, Cities. All values are reported in 2013 USD.
VA-fortified oil program and theVA-fortified bouil-
lon program effectively covered ∼5 and ∼7.7 m
CY, respectively, and saved 9724 and 16,068 lives,
respectively.
There was subnational variation for all measures
of program impact, especially for reach, due pri-
marily to variations in diets and in the consump-
tion of fortifiable products across macroregions.
Cross-macroregional differences in effective cover-
age and deaths averted were also evident for all VA
intervention programs, but were most notable for
VAS, biofortified maize, and bouillon cubes; these
differences were primarily attributable to lower VA
intake in the North macroregion, and to maize con-
sumption patterns (more common in the North
macroregion).
VA intervention program costs varied substan-
tially across the candidate programs examined
in Table 1. The biofortified maize program was
the least expensive (∼$1.4 m over 10 years), fol-
lowed by the continuation of the low-performing
VA-fortification program for oil (∼$2.7 m over
10 years), followed by theVA-fortified bouillon pro-
gram (∼$2.9 m over 10 years), and the improved
VA-fortified oil program (∼$4.9 m over 10 years).
The most expensive program, by far, was the VAS
program (∼$27 m over 10 years).
As was the case for program effects, pro-
gram costs and cost-effectiveness also varied across
macroregions. For example, cost per child death
averted for the VAS program varied from $3333 in
the South to $643 in the North.
Assessing the nutritional benefits and costs
of combinations of VA programs
The BAU scenario. Cameroon already invests in
two national programs to meet children’s VA needs:
a national VA-fortified edible oil programq and a
twice-yearly CHD program during which VAS is
provided to all children between the ages of 6 and
59 months.r For simulation purposes, we assumed
that the current set of programs would be pursued
for a decade (Y1–Y10), with the effects and costs
summarized below (Table 2). On average, approx-
imately 1.3 m children are effectively covered each
year through this pair of programs. However, these
programs are costly—on average, these programs
cost approximately US$3 m per year.s
Over a 10-year period, the pair of VA inter-
vention programs effectively covers approximately
12.8 m CY and costs approximately US$30 m, for
an average cost of approximately US$2.34 per child-
year effectively covered (Table 3).
However, these summary national measures of
effects and cost-effectiveness mask very substan-
tial subnational differences (Table 3). The major-
ity of CY effectively covered occur in the North
macroregion, where VAD prevalence rates are high-
est and cost per effectively covered child by the VAS
program is lowest. Comparing cost-effectiveness
qIn the “current program” considered here, oils contained
approximately 44% of target fortification levels.
rThese macroregion-specific levels of reach are retained
throughout the 10-year model simulation period.
DW tablets are also provided during these national
campaigns—these tablets are not included in this analysis
because the effects on VAD are modest and hence rarely
appear in the list of cost-effective VA interventions
selected by the economic optimization model.
s Increases over time in effective coverage and total costs
are attributable to growth in the under-5 population
and not to changes in dietary intake or VA intervention
program reach.
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Table 3. Undiscounted 10-year total costs and child-years effectively covered for business-as-usual vitamin A inter-
vention programs for preschool children in Cameroon, nationally and by macroregion
National North South Cities
Number of child-years effectively covered (’000s) 12,836 6916 3503 2417
Total cost (’000s USD) $30,051 $9968 $14,062 $6021
Cost per child-year effectively covered (USD/child-year) $2.34 $1.44 $4.01 $2.49
Note: All values are reported in 2013 USD.
measures across macroregions (e.g., $4.01/child-
year effectively covered in the South versus $1.44
in the North) suggests that shifting the focus of VA
intervention programs toward the North macrore-
gion may yield efficiency gains.
The economically optimal scenario. The results
(Table 4) of the bioeconomic optimization model
(aiming to cover at least the same number of CY
nationally over the 10-year planning time horizon
more cost-effectively than the BAU scenario, and
selecting from a broader set of VA intervention pro-
grams) confirm the potential for VA intervention
program efficiency gains. The enhanced fortified
cooking oil program and the VA-fortified bouil-
lon cube program are selected by the model, even
though the former does not reach peak performance
until the fourth year of the simulation time horizon
(Y4), and the latter faces costs but generates no ben-
efits until Y4. Note also that the biofortified maize
program is not selected. Although it is a relatively
inexpensive program that reaches many millions of
children, this intervention is predicted to effectively
cover few children in this age range (given observed
maize intakes and the modeled levels of maize beta-
carotene contentt), and hence is not cost-effective
for this targeted beneficiary group. Finally, and per-
haps most importantly, VAS is only selected for the
Northmacroregion, and even there only for the first
2 years of the simulation period (again, with the
optimization model objective being only to meet, at
least, the BAU benefits over the same time period);
the VAS program is discontinued once the benefits
of the fortified oil and fortified bouillon cube pro-
grams become available to children.u
By design, the economically optimal set of VA
programs effectively covers at least as many CY
as the BAU scenario (Table 5); indeed, total effec-
tive coverage is a bit higher. The economically
optimal strategy retains a geographic focus on the
tWe assume ∼15 μg beta-carotene per gram dry maize,
using 12:1 equivalency. If bioconversion is higher from
maize, thenwewould underestimate the effect of this pro-
gram. That said, we do not include any adjustment for
retention, and we are certainly being overly optimistic by
assuming 100% replacement.
uWe did not explore alternative VAS distribution plat-
forms; this will be the focus of future work.
Table 4. Economically optimal set of vitamin A intervention programs for children in Cameroon over time, and
their annual total costs and resulting child-years effectively covered
Y1 Y2 Y3 Y4 Y5 Y6 Y7 Y8 Y9 Y10
VA supplementation N N
Fortified edible oils
(44–72–100%)
SNCa SNCa SNCa SNC SNC SNC SNC SNC SNC SNC
Fortified bouillon cubes SNCb SNCb SNCb SNC SNC SNC SNC SNC SNC SNC
Number of child-years effectively
covered (’000s)
998 1188 873 1415 1435 455 1475 1496 1516 1536
Total cost (’000s USD) $1472 $1478 $598 $855 $855 $855 $855 $855 $855 $855
aIndicates a program year with some, but incomplete nutritional benefits.
bIndicates a program year with no nutritional benefits. SNC refers to macroregions in Cameroon: S, South; N, North; and C, Cities.
All values are reported in 2013 USD.
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Table 5. Undiscounted 10-year total costs and child-years effectively covered for the economically optimal set of
vitamin A intervention programs for preschool children in Cameroon, nationally and by macroregion
National North South Cities
Number of child-years effectively covered (’000s) 13,086 6558 4038 2789
Total cost (’000s USD) $9537 $4544 $3048 $1945
Cost per child-year effectively covered (USD/child-year) $0.71 $0.69 $0.75 $0.70
Note: All values are reported in 2013 USD.
North macroregion (51% of all effectively covered
CY), but covers 757 (11%) fewer children in the
North macroregion than the BAU strategy, with
more CY being effectively covered in the South
macroregion (180, 5%) and in the cities (152, 7%).v
Cost savings of this complete shift in VA inter-
vThis spatial shift in effective coverage vis-à-vis the BAU
scenario is attributable to the increased effectiveness of
the food and condiment fortification programs, which
vention programs are large: total program costs
over the 10-year simulation period fall from about
$30.1 m (BAU scenario) to approximately $9.5 m,
and the national average cost per child-year
helped meet the required threshold for effectively cov-
ered children in the Cities and South macroregions,
thereby reducing the number of years of VAS in the North
macroregion required to meet the target for effective
coverage over 10 years.
A
C D
B
Figure 1. Vitamin A program intervention pathway for children 6–59 months of age in the South macroregion of Cameroon,
including (A) components of the VA program over a 10-year planning horizon, (B) prevalence of inadequate dietary vitamin A
intake among children, (C) number of lives saved among children by fortification programs (yellow line) and total vitamin A
programs (orange line), and (D) costs (in 2013 USD) for fortification programs (yellow line) and total vitamin A programs with
a single (blue) or two (gray) validation surveys. The increasingly shaded areas associated with VA-fortified edible oils in panel A
indicate the shift from 44% to 72% to 100% (by Y3) in reaching the targeted levels of fortification. The parenthetical Xs associated
with VA-fortified bouillon cube indicate that zero nutritional benefits are generated until Y4.
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Table 6. Selected summary measures of Monte Carlo simulations of optimization model resultsa
Measure Point estimate (95% interval) or %
Number of effectively covered child-years over 10 years (’000s) 13,386 (12,955–14,195)
Total cost over 10 years (’000s $) $9537 ($8709–$11,067)
Cost per child-year effectively covered ($/child-year) $0.71 ($0.64–$0.82)
Monte Carlo simulation results that include the selected program (%)
Enhanced VA-fortified edible oils 100
VA-fortified bouillon cubes 100
VAS in the North macroregionb 99.5
VAS in the South macroregion 0
VAS in the Cities macroregion 5.5
VA-biofortified maize 11.3
Note: All values are reported in 2013 USD.
aOptimization model simulations were run with the objective of effectively covering at least as many children as the business-as-
usual scenario, over a 10-year time horizon, using candidate vitamin A interventions: vitamin A–fortified edible oil or bouillon cube,
high-dose vitamin A supplements (VAS), or vitamin A–biofortified maize.
bThe criterion for counting VAS as having been included in a given simulation was that the intervention appears at least three times
over the 10-year simulation time horizon.
effectively covered falls from $2.34 (BAU sce-
nario) to $0.71. Finally, although the number of CY
effectively covered by macroregion has remained
similar to that of the BAU scenario, the ratios of the
macroregion-specific average cost per effectively
covered child-year to the national average cost per
effectively covered child-year are somewhat more
uniform; themodel has reallocated resources across
programs, across macroregions, and over time on
the basis of cost-effectiveness.
The simulated values and their 95% intervals (in
parentheses) appear in Table 6. Note in the sec-
ond half of Table 6 that the three intervention pro-
grams chosen by the economically optimal solution
presented in Table 4 (namely, VA-fortified bouil-
lon cubes, enhanced VA-fortified edible oils, and
VAS targeted to the North macroregion) appear in
essentially all of the 1000 Monte Carlo simulation
results. The competing VAS programs in the MIN-
IMOD tool (namely, VAS in the Cities and South
macroregions) are selected in only a small fraction
of those simulation results, and the VA-biofortified
maize appears in slightly over 11% of these simula-
tion results.
Policy pathways for transitioning to more cost-
effective VA intervention programs. The MINI-
MOD tool identifies the national economically opti-
mal strategy for implementing cost-effective MN
intervention programs. Yet, transitioning from the
BAU to this lowest-cost collection of VA interven-
tion programs will require investments and time,
and national, regional governments, and partners
may have strong preferences regarding managing
VAD at different spatial scales and over different
time horizons. The MINIMOD tool allows poli-
cymakers to identify macroregion-specific policy
pathways and to specify alternative objectives. We
present the results for three macroregions (sepa-
rately), below, and also shift the focus from achiev-
ing national BAU effective coverage results to elimi-
nating VAD in each macroregion.
The South macroregion. In the policy pathways
analysis, the VAS program is maintained in the
South until Y6 (Fig. 1A), as part of the orig-
inal GAVA framework involving two validation
studies in nonconsecutive years (more on this,
below).
At the beginning of the simulation period, 19%
of children have inadequate intake (Fig. 1B). As
the VA-fortified oil program becomes more effec-
tive, this prevalence declines, but even when oil
is fortified at 100% of the target amount of VA,
the prevalence of inadequate intake remains above
the 2.5% rate selected as the threshold to indicate
adequate population VA intake. Once the bene-
fits of VA-fortified bouillon cubes become available
(in Y4), overall VAD prevalence rates fall to 2.3%;
hence, inadequate VA dietary intake is considered
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Figure 2. Vitamin A program intervention pathway for children 6–59 months of age in the Cities macroregion of Cameroon,
including (A) components of the VA program over a 10-year planning horizon, (B) prevalence of inadequate dietary vitamin A
intake among children, (C) number of lives saved among children by fortification programs (yellow line) and total vitamin A
programs (orange line), and (D) costs in 2013 USD for fortification programs (yellow line) and total vitamin A programs with
a single (blue) or two (gray) validation surveys. The increasingly shaded areas associated with VA-fortified edible oils in panel A
indicate the shift from 44% to 72% to 100% (by Y3) in reaching the targeted levels of fortification. The parenthetical Xs associated
with VA-fortified bouillon cube indicate that zero nutritional benefits are generated until Y4.
resolved in Y4. However, as per the GAVA proto-
col, VAS is continued until 2018, at which point two
validation studiesw have been conducted (in Y4 and
Y6); assuming these exercises confirm the effective-
ness of the two fortification programs for reduc-
ing the prevalence of VAD, VAS is discontinued
in Y7.
The total number of lives lost that are attributable
to VAD in the South is approximately 780 annu-
ally (Fig. 1C), with some change over time due to
increases in the under-5 population—this repre-
sents the largest number of lives that any combi-
wThese are population-based surveys undertaken to con-
firm that VAD is no longer occurring at a prevalence con-
sidered to be a public health problem.
nation of VA intervention programs can save.x At
the outset of the simulation period, 353 lives are
saved by the VA fortification programs; VAS saves
approximately an additional 225 lives. As the invest-
ments in the fortification programs begin to con-
tribute higher amounts of dietaryVA, the number of
lives saved by these programs increases, and reaches
a plateau at approximately 777 lives saved in Y4. At
that point, theVASprogram’smarginal contribution
to lives saved is very small.
When mature, the VA food fortification pro-
grams jointly cost approximately $336,000 per year
to implement, including M&E costs (Fig. 1D). VAS
undertaken via CHDs costs approximately $1.3 m
xYoung children die frommany causes that are not related,
directly or indirectly, to VAD.3
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Figure 3. Vitamin A program intervention pathway for children 6–59 months of age in the North macroregion of Cameroon,
including (A) components of the VA program over a 10-year planning horizon, (B) prevalence of inadequate dietary vitamin A
intake among children, (C) number of lives saved among children by fortification programs (yellow line) and total vitamin A
programs (orange line), and (D) costs in 2013 USD for fortification programs (yellow line) and total vitamin A programs with
a single (blue) or two (gray) validation surveys. The increasingly shaded areas associated with VA-fortified edible oils in panel A
indicate the shift from 44% to 72% to 100% (by Y4) in reaching the targeted levels of fortification. The parenthetical Xs associated
with VA-fortified bouillon cube indicate that zero nutritional benefits are generated until Y4.
per year, and the validation studies cost approxi-
mately $450,000 in each of the years they are under-
taken. The choice to conduct only one validation
study (instead of the two surveys recommended in
the original GAVAbriefy) extends the period of pro-
grammatic savings by 2 years, eliminating 2 years
of VAS and one validation study (approximately
$3.0 m total).
The Cities macroregion. The strategy plays out
essentially the same way in the Cities macroregion
(Fig. 2A). The VA-fortified oil and bouillon cube
programs (combined) deliver sufficient amounts of
dietary VA to children to reduce the prevalence of
inadequate VA intake to below 2.5% by Y4 (Fig. 2B).
The total number of children’s lives lost to VAD
in the Cities macroregion annually (approximately
yThis choice would, however, be consistent with the
updated GAVA framework.
355, Fig. 2C) is estimated to be approximately half
of that of the South macroregion. In Y1, the forti-
fication programs save 267 lives; the VAS program
saves an additional 84 lives. Again, as in the South
macroregion, the number of additional lives saved
by VAS after the food fortification programsmature
is quite small.
Because population concentrations are higher in
the Cities macroregion than in the South macrore-
gion, the costs of VAS distribution and the two val-
idation studies are lower in the former (Fig. 2D).
As was the case in the South macroregion, cost sav-
ings would accrue earlier if programmatic change is
based on a single validation study as suggested by
the updated GAVA framework.
The North macroregion. The policy pathway is
very different in the North macroregion (Fig. 3A),
where the baseline prevalence of inadequate VA
intake is much higher and is never completely
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Figure 4. Estimated summary costs in 2013 USD of three 10-year scenarios for vitamin A intervention programs in Cameroon,
nationally and by macroregion: (A) continuing the business-as-usual scenario, (B) pursuing a path toward a more cost-effective
set of vitamin A intervention programs, including one validation survey; and (C) pursuing a path toward a more cost-effective set
of VA intervention programs, including two validation surveys undertaken in nonconsecutive years.
addressed by food fortification programs included
in the model. While the combined VA-fortified
oil and bouillon cube programs do considerably
reduce inadequate VA intake in the under-5 pop-
ulation (from 60% to 20%, Fig. 3B), they never
deliver sufficient amounts of dietary VA to a suffi-
cient proportion of the population to bring preva-
lence rates below the 2.5% cutoff. Therefore, the
efficient 10-year VA intervention program strategy
retains VAS for children for the entire simulation
period.
The estimated number of lives lost due to VAD
in the North macroregion (Fig. 3C) is much larger
than that in either of the other two macroregions
in Cameroon. The combined food fortification pro-
grams do contribute significantly to reducing child
mortality when they mature, but the VAS program
continues to save hundreds of additional lives per
year.
Finally, because the VAS program must be main-
tained throughout the 10-year simulation period in
the North macroregion, total VA intervention pro-
gram costs remain high (Fig. 3D). One validation
study is carried out in Y4, but it is expected to con-
firm model results (that prevalence of VAD among
children remains unacceptably high), so a second
validation study is not needed.z
Policymakers need to know the costs associated
with alternative VA intervention programs, includ-
ing the macroregion-specific costs of pursuing vali-
dation studies prior to curtailing VAS programs (if
validation studies confirm that VAD is no longer
a public health problem). Figure 4 provides esti-
mates of the summary costs of three, 10-year scenar-
ios, nationally and by macroregion: (1) continuing
the BAU scenario; (2) pursuing a path toward a
more cost-effective set of VA intervention pro-
grams, including one validation study; and (3) pur-
suing a path toward a more cost-effective set of
VA intervention programs, including two validation
studies undertaken in nonconsecutive years, as sug-
gested by the original GAVA framework. Nationally,
zOne could argue that no validation study is needed in the
North macroregion if available data indicate that VAD is
unlikely to have decreased, although conducting a nutri-
tion survey at this pointmay be of use for planning further
programs to address VAD. Eliminating this study would
reduce costs.
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maintaining the BAU set of programs is the most
expensive option over 10 years. Adopting the pol-
icy pathway that includes one validation study saves
approximately ∼$5 m, while the original GAVA-
recommended two-validation pathway would save
∼$1 m over 10 years. Recall that the costs associ-
ated with the two-validation-study scenario include
the costs of maintaining a VAS program for 2 years
longer than the one-validation-study scenario. Note
also that maintaining VAS programs while fortifi-
cation programs mature, and while the results of
model simulations are validated in the field, will
reduce the time period during which efficiency
gains associated with programmatic investments
can accrue. This is especially true for the two-
validation-study case, which allows efficiency gains
to begin to accrue only in Y7 of a 10-year modeling
time horizon. Extending themodeling time horizon
would increase realized efficiency gains and dramat-
ically increase cost savings.
Discussion
We share the global commitment to achieving sus-
tainable, food-based solutions to MN deficiency
problems, and to identifying the policies, technolo-
gies, and institutional arrangements that will cre-
ate and support them. However, in the short and
medium terms, dietary intakes in the absence of
large-scale food fortification are likely to fall short of
providing the amounts and types of MN required—
this is especially true among children as well as
women of reproductive age (WRA) in resource-
poor households in developing countries. For these
populations, the fortification of staple foods can
contribute significantly to achieving dietary ade-
quacy, but in some settings, even combinations of
food fortification programs will not meet needs. In
such cases, direct supplementation will be required.
High-dose VAS has been distributed through
twice-annual campaigns in LMIC for decades as a
strategy to reduce childmortality.When VAS stake-
holders are asked to cover the operational costs of
the campaign (versus just covering the costs of pro-
viding capsules), as may become more likely as vac-
cination campaigns are phased out, this platform
becomes quite expensive and thus unsustainable.10
Evidence-based strategies are needed to allow coun-
tries to transition tomedium- and long-term strate-
gies to ensure adequate VA intake and to reduce
VAD-related morbidity and mortality.
We used the MINIMOD tool and data for
Cameroon to estimate the costs and likely
nutritional impacts of various VA intervention
programs—some of which have the potential to be
implemented subnationally—on VA dietary ade-
quacy and VA-attributable deaths averted among
young children.
Several important points emerge from the exam-
ination of the effects and costs of individual VA
intervention programs. First, as we have shown in
earlier work,17 the ranking of program effective-
ness varies considerably depending on the measure
of impact chosen, for example, selecting reach as a
program objective will yield a very different selec-
tion of VA intervention programs than would be
the case if lives saved were chosen as a program
objective. Second, there is considerable variation
in the costs associated with VA intervention pro-
grams. Third, the effects, costs, and (hence) cost-
effectiveness of all programs vary subnationally.
These differences in cost-effectiveness, across pro-
grams, across macroregions, and over time, suggest
that efficiency gains might be achievable by shift-
ing resources from less cost-effective programs and
macroregions to more cost-effective programs and
macroregions.
We also modeled combinations of investments
in addressing VAD, for example, investing approx-
imately $2.2 m over 3 years to improve the effec-
tiveness of the VA oil fortification program from
its baseline of 44% of targeted amount of fortifica-
tion to 75% (Y2), to 100% (Y3–Y10), and invest-
ing $2.9 m in the establishment, promotion, and
launching andM&E of VA-fortified bouillon cubes,
which would become available via retail outlets and
(hence) begin to generate nutritional benefits in
Y4. The strategy modeled also retains VAS for at-
risk children until the prevalence of inadequate VA
intake falls below 2.5%, at which point inadequate
VA intake would be expected to have decreased
to thresholds suggesting that VAD is no longer
a public health problem. The 2.5% threshold for
inadequate intake was based on general targets for
food fortification programs because there are no
formal guidelines for the prevalence of inadequate
intake that indicates a public health problem (or lack
thereof), or that corresponds to a given prevalence
of (biochemically determined) VAD. As estimates
of dietary intake become less stable at the tails of
the distribution (e.g., <10% of the population), a
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slightly higher threshold may also be appropriate.
Specific guidance is needed on decision-making
thresholds for each type of data, as more countries
seek to use dietary data to guide such programmatic
decisions.
As expected, the pathways from BAU toward
the more cost-effective combinations of VA inter-
vention programs varied by macroregion. There
are some commonalities, though. First, the model
selects the national enhanced VA-fortified edible
oils (over the current fortification program, in
which only 44% of the target level of VA fortifica-
tion is being achieved) despite its higher cost. Sec-
ond, a national program to fortify bouillon cubes
is chosen, despite its 3-year start-up period during
which costs are faced but no nutritional benefits are
delivered. Third, the national VA-biofortifiedmaize
program is not selected—costs are relatively low, but
nutritional benefits for young children are low, too.
These analyses provide concrete and practical
guidance for Cameroon regarding the cost-effective
management of VAD, nationally and subnationally.
They can also serve as a model for other countries
to develop evidence-based options for transition-
ing from short- tomedium-termVADmanagement
strategies.
Importantly, these modeling results assume that
intervention programs, including the M&E activ-
ities associated with them, are all operating at
the levels modeled. This does not mean that we
assume that programs reach 100% of the popula-
tion (reach estimates are based on survey data), but
we do assume that program performance is con-
stant over time, or that it follows the performance
trend included in the model. Inadequate program
implementation would reduce the predicted impact
on VA intake. Program implementation should be
continuously monitored, and these data used to
guide efforts to improve program performance. In
addition, the validation studies recommended by
the GAVA framework are critical to confirm that
population VA status is adequate before withdraw-
ing VAS programs. The updated GAVA frame-
work does not specify the need for repeated val-
idation studies before withdrawing VAS (as long
as sufficient data are available to confirm ade-
quate dietary VA intake); compared with the two-
validation framework, this approach saves field
research costs and extends the timeframe for accru-
ing programmatic savings associated with ending
VAS. Finally, any programmatic changes should be
accompanied by activities to monitor population
status, including child mortality rates in the case of
countries or regions considering withdrawing VAS
programs.
Limitations
The research underlying this paper has several limi-
tations. First, the start-up and ongoing costs ofM&E
activities associated with all VA intervention pro-
grams are included in allmodel simulations, and it is
assumed that these M&E activities are in place and
operating as intended. This is a perennial challenge
in the context of developing countries, and third-
party confirmation may be required.
Second, the results presented are taken from
a case study of Cameroon, an agroecologically
and culturally diverse country, and consequently
with a broad array of dietary intake patterns and
geographic variation in MN deficiencies. Other
sites may be less diverse, and their resident pop-
ulations may therefore have more similar diets
and prevalence rates of MN deficiencies. However,
even within homogeneous agroecologies, dietary
differences may exist among different socioeco-
nomic groups, and in rural versus urban settings.
Therefore, throughout other LMIC, one should
expect to find dietary differences and consequently
differences in the prevalence rates and severities of
inadequate MN dietary intake. Regardless of the
reasons for such variability, the approach adopted,
and the analyses undertaken here, will generally be
useful.
Third, otherMNdeficiencies (e.g., iron) canmat-
ter greatly for children and other beneficiary groups
in Cameroon, and some of the products that could
be included in this analysis (e.g., multiple MN pow-
ders) can address these deficiencies. The benefits
that these products might contribute to addressing
MN deficiencies other than VA are not included in
this analysis—doing so would increase the chances
of, but would not guarantee, their being included
in the economically optimal set of MN intervention
programs.
Fourth, some MN intervention programs convey
other products or information that may be useful in
addressing VAD. For example, in addition to VAS,
CHD often provide DW tablets and guidance to
mothers regarding breastfeeding, both of which can
affect the VA status of children. Neither the benefits
177Ann. N.Y. Acad. Sci. 1465 (2020) 161–180 © 2019 The Authors. Annals of the New York Academy of Sciences
published by Wiley Periodicals, Inc. on behalf of New York Academy of Sciences
Meeting children’s vitamin A needs in Cameroon Vosti et al.
(in terms of estimated improvements in VA status)
or the costs of these elements of CHD programs are
included in this analysis, although previous analy-
ses suggest that the contribution of DW tablets to
improved VA status is small.15
Fifth, this paper focuses exclusively on young
children, on VAD among them, and on the impacts,
costs, and cost-effectiveness of alternative combina-
tions of VA intervention programs to address VAD.
There are other groups in society who suffer from
the consequences of VAD, for example, WRA, who
would not benefit from some of the interventions
addressed in this analysis (e.g., CHD) but would
benefit from other programs (e.g., VA-fortified edi-
ble oil). The cobenefits to WRA of fortification
programs are not included in the analyses presented
here, but if they were, they would strengthen the
case for their inclusion in the cost-effective strategy.
However, VA-biofortified maize, which the model
does not select because it delivers very little dietary
VA to children, may well be selected as a cost-
effective program if the focuswere to shift to include
WRA. These and other cobenefits are worthy of
further study.
Sixth, the estimated effects of the benefits of MN
intervention programs are based on detailed dietary
intake data that are now somewhat dated (original
data were collected in 2009), and these data do not
account for seasonal variations in dietary intake.
Changes in food consumption habits and breast-
feeding patterns could alter baseline MN intake in
ways that might affect the marginal impacts of MN
intervention programs, but we do not believe that
the core policy messages included in this paper
would be affected.
Seventh, as with any modeling effort, it was nec-
essary tomake certain assumptions to fully populate
the tool. For example, we present single estimates of
lives saved (calculated using the LiST model) rather
than ranges attributable to, for example, uncer-
tainty regarding cause-specific mortality rates at
subnational level. However, model robustness tests
strongly suggest that even when uncertainty regard-
ing benefits and costs is introduced into the MIN-
IMOD tool, the policy messages included in this
paper are not affected.
Eight, we did not explore the impacts, costs, or
cost-effectiveness of alternative distribution models
or platforms for VAS. This will be the focus of future
work.
Finally, the costs associated with MN interven-
tion programs included in the tool are somewhat
dated (2013–2014) and these costs are held con-
stant over the simulation timeframe, with the excep-
tion of costs that vary with the size of the target
population (preschool children). In reality, these
costs may vary over time, perhaps especially for
CHD programs. However, sensitivity analyses sug-
gest that core policy messages are robust to uncer-
tainty related to costs and nutritional benefits.
Conclusions and policy implications
Appropriate and timely data collection, analysis,
and interpretation efforts are needed to document
and understand the prevalence and severity of
VAD, and the spatial patterns of deficiency. National
and subnational perspectives and policies are
needed to establish and manage cost-effective
strategies for addressing VAD.
The GAVA framework provides guidance for
countries with ongoing VA fortification programs
that are consideringwithdrawingVAS.However, for
countries at an earlier stage, efforts should focus on
putting in place cost-effective strategies to address
VAD. Methods and tools, such as those devel-
oped through the MINIMOD project, are needed
to develop, prioritize, and strengthen national and
subnational programs over time to address under-
lying VA intake and status.
In these simulations for Cameroon, the current
edible oil fortification program is predicted to con-
tribute to meeting VA needs of young children;
improving program management can increase its
effectiveness and cost-effectiveness. Initiating a VA-
fortified bouillon cube program could also make
cost-effective contributions to addressing VAD. In
the South and Cities macroregions, these programs,
once mature, are predicted to reduce inadequate
VA intake among children to less than 2.5%, sug-
gesting that dietary VA intake is adequate for that
population. Once these predictions are validated in
accordance with the GAVA framework, VAS pro-
grams can be curtailed, since their contributions
to reducing VA-attributable child mortality will be
very small. In the North macroregion, the mature
food fortification programs included in this analy-
sis are not predicted to reduce inadequate VA intake
among children sufficiently to allow for the cessa-
tion of VAS programs.
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Several important policy messages emerge. First,
continuing the BAU is the costliest of the strategies
explored here—all of which achieve essentially the
same number of effectively covered CY and avert
essentially the same number of VA-preventable
child deaths. Thus, it is worthwhile to plan the pro-
cess to transition to cheaper and more sustainable
strategies to address VAD.
Second, investments in and better management
of VA intervention programs can significantly
reduce the cost of meeting children’s VA needs. For
example, enhancing the performance of the VA-
fortified oil program, investing in a VA-fortified
bouillon cube program, and focusing VAS activi-
ties in the Northmacroregion would save over $5m
(>17% of total costs).
Third, the choice of one versus two validation
studies has large fiscal consequences; for example,
2 years of additional VAS plus a second validation
study in the southmacroregion costs approximately
US$2.9 m, but is still less expensive than continuing
BAU indefinitely.
Fourth, the results presented here envision 3-
year periods for upgrading the VA-fortified oil pro-
gram, and for designing and implementing the
VA-fortified bouillon cube program. There are sub-
stantial savings associated with speeding up these
processes and substantial reductions in savings
associated with delays. Gains from effective M&E
programs are also large. Hence, policymakers have
very substantial fiscal incentives to design and
implement new programs quickly, and to manage
new and existing programs well.
Finally, and very importantly, detailed nationally
representative data on dietary intake and biomark-
ers, and onMN intervention program costs, are nec-
essary to identify the expected benefits and costs of
alternative strategies for addressing MN deficien-
cies, and hence to formulate sound MN interven-
tion policies. A recent report highlighted the lack
of recent data on VAD prevalence among coun-
tries with VAS distribution programs.29 Without
such data, the site-specific extent of MN deficien-
cies is challenging to estimate, nor can cost-effective
sets of national and subnational programs be confi-
dently designed or managed. In some settings, rel-
atively inexpensive food fortification programs can
eliminate some MN deficiencies; in other settings,
more expensive combinations of programs may be
required. However, without the proper underlying
empirical data, policymakers cannot reasonably for-
mulate cost-effective strategies for solvingMN defi-
ciency problems. New approaches and tools have
reduced the costs of data collection and analysis,
making them more accessible to all. Collecting and
analyzing such data is a policy choice and should be
considered a very high priority.
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